If present, this could in part explain the known side effect of hypertriglyceridemia seen in horses treated with SGLT2i [17, 55], as increased glucagon secretion leads to gluconeogenesis, glycogenolysis and lipolysis. Here, GCG is linked to hypertriglyceridemia.